637 related articles for article (PubMed ID: 14616371)
41. Sentinel lymph node status in melanoma: a valuable prognostic factor?
Topar G; Eisendle K; Zelger B; Fritsch P
Br J Dermatol; 2006 Jun; 154(6):1080-7. PubMed ID: 16704637
[TBL] [Abstract][Full Text] [Related]
42. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients.
Schmid-Wendtner MH; Berking C; Baumert J; Schmidt M; Sander CA; Plewig G; Volkenandt M
J Am Acad Dermatol; 2002 Jun; 46(6):874-9. PubMed ID: 12063484
[TBL] [Abstract][Full Text] [Related]
44. The metastasizing thin cutaneous melanoma. Case report.
Lock-Andersen J; Hastrup NC; Drzewiecki KT
Scand J Plast Reconstr Surg Hand Surg; 1989; 23(2):153-5. PubMed ID: 2814386
[TBL] [Abstract][Full Text] [Related]
45. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
[TBL] [Abstract][Full Text] [Related]
46. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
47. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
[TBL] [Abstract][Full Text] [Related]
48. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
[TBL] [Abstract][Full Text] [Related]
49. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
[TBL] [Abstract][Full Text] [Related]
50. A rational approach to the follow-up of melanoma patients.
Garbe C
Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
[TBL] [Abstract][Full Text] [Related]
51. Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype.
Baumert J; Schmidt M; Giehl KA; Volkenandt M; Plewig G; Wendtner C; Schmid-Wendtner MH
Melanoma Res; 2009 Feb; 19(1):24-30. PubMed ID: 19430403
[TBL] [Abstract][Full Text] [Related]
52. Prognosis of thin cutaneous head and neck melanoma (<1mm).
Andersson AP; Dahlstróm KK; Drzewiecki KT
Eur J Surg Oncol; 1996 Feb; 22(1):55-7. PubMed ID: 8846868
[TBL] [Abstract][Full Text] [Related]
53. Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography.
Schmid-Wendtner MH; Partscht K; Korting HC; Volkenandt M
Arch Dermatol; 2002 Apr; 138(4):491-7. PubMed ID: 11939811
[TBL] [Abstract][Full Text] [Related]
54. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
55. [Melanomas more serious in the elderly].
van der Meijden WA; van Bruchem-Visser RL; Thio HB; van der Cammen TJ
Ned Tijdschr Geneeskd; 2010; 154():A1535. PubMed ID: 20482904
[TBL] [Abstract][Full Text] [Related]
56. [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].
Tejera-Vaquerizo A; Barrera-Vigo MV; Fernández-Canedo I; Blázquez-Sánchez N; Mendiola-Fernández M; Fernández-Orland A; Bosch-García R; de Troya-Martín M; Herrera-Ceballos E
Actas Dermosifiliogr; 2007 Oct; 98(8):531-8. PubMed ID: 17919427
[TBL] [Abstract][Full Text] [Related]
57. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
58. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma.
Kunte C; Geimer T; Baumert J; Konz B; Volkenandt M; Flaig M; Ruzicka T; Berking C; Schmid-Wendtner MH
Melanoma Res; 2010 Aug; 20(4):330-7. PubMed ID: 20526218
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic analysis of 66 Japanese thin melanomas with metastasis of sentinel or regional lymph node.
Mori M; Sugiura M; Kono M; Matsumoto T; Sawada M; Yokota K; Yasue S; Shibata S; Sakakibara A; Nakamura S; Tomita Y; Akiyama M
J Cutan Pathol; 2013 Dec; 40(12):1027-34. PubMed ID: 24111935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]